Advertisement

Index by author

July 01, 2021; Volume 73,Issue 3

A

  1. Abiri, Ardavan

    1. Open Access
      Unlocking G-Quadruplexes as Antiviral Targets
      Ardavan Abiri, Marc Lavigne, Masoud Rezaei, Sanaz Nikzad, Peyman Zare, Jean-Louis Mergny and Hamid-Reza Rahimi
      Rhian Touyz, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 897-923; DOI: https://doi.org/10.1124/pharmrev.120.000230

B

  1. Barker, Eric

    1. The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions
      Open Access
      The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions
      Samantha Christine Sernoskie, Alison Jee and Jack Paul Uetrecht
      Eric Barker, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 861-896; DOI: https://doi.org/10.1124/pharmrev.120.000090

  2. Bekhbat, Mandy

    1. Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Michael J. Lucido, Mandy Bekhbat, David R. Goldsmith, Michael T. Treadway, Ebrahim Haroon, Jennifer C. Felger and Andrew H. Miller
      Robert Dantzer, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1084-1117; DOI: https://doi.org/10.1124/pharmrev.120.000043

  3. Bossert, Jennifer M.

    1. Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review
      Ida Fredriksson, Marco Venniro, David J. Reiner, Jonathan J. Chow, Jennifer M. Bossert and Yavin Shaham
      Michael Nader, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1050-1083; DOI: https://doi.org/10.1124/pharmrev.120.000191

C

  1. Cameron, Scott J.

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

  2. Chow, Jonathan J.

    1. Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review
      Ida Fredriksson, Marco Venniro, David J. Reiner, Jonathan J. Chow, Jennifer M. Bossert and Yavin Shaham
      Michael Nader, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1050-1083; DOI: https://doi.org/10.1124/pharmrev.120.000191

  3. Cooper, Matthew A.

    1. Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
      Open Access
      Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
      Sarah E. Corcoran, Reena Halai and Matthew A. Cooper
      Clive Page, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 968-1000; DOI: https://doi.org/10.1124/pharmrev.120.000171

  4. Corcoran, Sarah E.

    1. Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
      Open Access
      Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
      Sarah E. Corcoran, Reena Halai and Matthew A. Cooper
      Clive Page, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 968-1000; DOI: https://doi.org/10.1124/pharmrev.120.000171

D

  1. Dantzer, Robert

    1. Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Michael J. Lucido, Mandy Bekhbat, David R. Goldsmith, Michael T. Treadway, Ebrahim Haroon, Jennifer C. Felger and Andrew H. Miller
      Robert Dantzer, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1084-1117; DOI: https://doi.org/10.1124/pharmrev.120.000043

E

  1. Ebong, Eno E.

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

F

  1. Felger, Jennifer C.

    1. Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Michael J. Lucido, Mandy Bekhbat, David R. Goldsmith, Michael T. Treadway, Ebrahim Haroon, Jennifer C. Felger and Andrew H. Miller
      Robert Dantzer, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1084-1117; DOI: https://doi.org/10.1124/pharmrev.120.000043

  2. Fredriksson, Ida

    1. Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review
      Ida Fredriksson, Marco Venniro, David J. Reiner, Jonathan J. Chow, Jennifer M. Bossert and Yavin Shaham
      Michael Nader, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1050-1083; DOI: https://doi.org/10.1124/pharmrev.120.000191

G

  1. Goldsmith, David R.

    1. Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Michael J. Lucido, Mandy Bekhbat, David R. Goldsmith, Michael T. Treadway, Ebrahim Haroon, Jennifer C. Felger and Andrew H. Miller
      Robert Dantzer, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1084-1117; DOI: https://doi.org/10.1124/pharmrev.120.000043

  2. Gottesman, Michael

    1. Aldo-Keto Reductases and Cancer Drug Resistance
      Open Access
      Aldo-Keto Reductases and Cancer Drug Resistance
      Trevor M. Penning, Sravan Jonnalagadda, Paul C. Trippier and Tea Lanišnik Rižner
      Michael Gottesman, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1150-1171; DOI: https://doi.org/10.1124/pharmrev.120.000122

H

  1. Halai, Reena

    1. Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
      Open Access
      Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
      Sarah E. Corcoran, Reena Halai and Matthew A. Cooper
      Clive Page, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 968-1000; DOI: https://doi.org/10.1124/pharmrev.120.000171

  2. Han, Jihong

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

  3. Harding, Ian C.

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

  4. Haroon, Ebrahim

    1. Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Michael J. Lucido, Mandy Bekhbat, David R. Goldsmith, Michael T. Treadway, Ebrahim Haroon, Jennifer C. Felger and Andrew H. Miller
      Robert Dantzer, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1084-1117; DOI: https://doi.org/10.1124/pharmrev.120.000043

  5. Horenstein, Nicole A.

    1. Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors
      Roger L. Papke and Nicole A. Horenstein
      Habibeh Khoshbouei, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1118-1149; DOI: https://doi.org/10.1124/pharmrev.120.000097

I

  1. Ilyas, Iqra

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

  2. Isom, Lori

    1. New Aspects of Diabetes Research and Therapeutic Development
      Leslie S. Satin, Scott A. Soleimanpour and Emily M. Walker
      Lori Isom, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1001-1015; DOI: https://doi.org/10.1124/pharmrev.120.000160

J

  1. Jee, Alison

    1. The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions
      Open Access
      The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions
      Samantha Christine Sernoskie, Alison Jee and Jack Paul Uetrecht
      Eric Barker, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 861-896; DOI: https://doi.org/10.1124/pharmrev.120.000090

  2. Jonnalagadda, Sravan

    1. Aldo-Keto Reductases and Cancer Drug Resistance
      Open Access
      Aldo-Keto Reductases and Cancer Drug Resistance
      Trevor M. Penning, Sravan Jonnalagadda, Paul C. Trippier and Tea Lanišnik Rižner
      Michael Gottesman, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1150-1171; DOI: https://doi.org/10.1124/pharmrev.120.000122

K

  1. Kamato, Danielle

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

  2. Khoshbouei, Habibeh

    1. Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors
      Roger L. Papke and Nicole A. Horenstein
      Habibeh Khoshbouei, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1118-1149; DOI: https://doi.org/10.1124/pharmrev.120.000097

L

  1. Lavigne, Marc

    1. Open Access
      Unlocking G-Quadruplexes as Antiviral Targets
      Ardavan Abiri, Marc Lavigne, Masoud Rezaei, Sanaz Nikzad, Peyman Zare, Jean-Louis Mergny and Hamid-Reza Rahimi
      Rhian Touyz, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 897-923; DOI: https://doi.org/10.1124/pharmrev.120.000230

  2. Li, Hong

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

  3. Li, Zhuoming

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

  4. Little, Peter J.

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

  5. Liu, Peiqing

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

  6. Lucido, Michael J.

    1. Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Michael J. Lucido, Mandy Bekhbat, David R. Goldsmith, Michael T. Treadway, Ebrahim Haroon, Jennifer C. Felger and Andrew H. Miller
      Robert Dantzer, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1084-1117; DOI: https://doi.org/10.1124/pharmrev.120.000043

  7. Luo, Sihui

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

M

  1. Ma, Qiang

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

  2. Mergny, Jean-Louis

    1. Open Access
      Unlocking G-Quadruplexes as Antiviral Targets
      Ardavan Abiri, Marc Lavigne, Masoud Rezaei, Sanaz Nikzad, Peyman Zare, Jean-Louis Mergny and Hamid-Reza Rahimi
      Rhian Touyz, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 897-923; DOI: https://doi.org/10.1124/pharmrev.120.000230

  3. Michel, Martin

    1. The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors
      Dean Paes, Melissa Schepers, Ben Rombaut, Daniel van den Hove, Tim Vanmierlo and Jos Prickaerts
      Martin Michel, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1016-1049; DOI: https://doi.org/10.1124/pharmrev.120.000273

  4. Miller, Andrew H.

    1. Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Michael J. Lucido, Mandy Bekhbat, David R. Goldsmith, Michael T. Treadway, Ebrahim Haroon, Jennifer C. Felger and Andrew H. Miller
      Robert Dantzer, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1084-1117; DOI: https://doi.org/10.1124/pharmrev.120.000043

N

  1. Nader, Michael

    1. Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review
      Ida Fredriksson, Marco Venniro, David J. Reiner, Jonathan J. Chow, Jennifer M. Bossert and Yavin Shaham
      Michael Nader, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1050-1083; DOI: https://doi.org/10.1124/pharmrev.120.000191

  2. Nikzad, Sanaz

    1. Open Access
      Unlocking G-Quadruplexes as Antiviral Targets
      Ardavan Abiri, Marc Lavigne, Masoud Rezaei, Sanaz Nikzad, Peyman Zare, Jean-Louis Mergny and Hamid-Reza Rahimi
      Rhian Touyz, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 897-923; DOI: https://doi.org/10.1124/pharmrev.120.000230

P

  1. Paes, Dean

    1. The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors
      Dean Paes, Melissa Schepers, Ben Rombaut, Daniel van den Hove, Tim Vanmierlo and Jos Prickaerts
      Martin Michel, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1016-1049; DOI: https://doi.org/10.1124/pharmrev.120.000273

  2. Page, Clive

    1. Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
      Open Access
      Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
      Sarah E. Corcoran, Reena Halai and Matthew A. Cooper
      Clive Page, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 968-1000; DOI: https://doi.org/10.1124/pharmrev.120.000171

  3. Papke, Roger L.

    1. Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors
      Roger L. Papke and Nicole A. Horenstein
      Habibeh Khoshbouei, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1118-1149; DOI: https://doi.org/10.1124/pharmrev.120.000097

  4. Penning, Trevor M.

    1. Aldo-Keto Reductases and Cancer Drug Resistance
      Open Access
      Aldo-Keto Reductases and Cancer Drug Resistance
      Trevor M. Penning, Sravan Jonnalagadda, Paul C. Trippier and Tea Lanišnik Rižner
      Michael Gottesman, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1150-1171; DOI: https://doi.org/10.1124/pharmrev.120.000122

  5. Prickaerts, Jos

    1. The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors
      Dean Paes, Melissa Schepers, Ben Rombaut, Daniel van den Hove, Tim Vanmierlo and Jos Prickaerts
      Martin Michel, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1016-1049; DOI: https://doi.org/10.1124/pharmrev.120.000273

R

  1. Rahimi, Hamid-Reza

    1. Open Access
      Unlocking G-Quadruplexes as Antiviral Targets
      Ardavan Abiri, Marc Lavigne, Masoud Rezaei, Sanaz Nikzad, Peyman Zare, Jean-Louis Mergny and Hamid-Reza Rahimi
      Rhian Touyz, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 897-923; DOI: https://doi.org/10.1124/pharmrev.120.000230

  2. Reiner, David J.

    1. Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review
      Ida Fredriksson, Marco Venniro, David J. Reiner, Jonathan J. Chow, Jennifer M. Bossert and Yavin Shaham
      Michael Nader, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1050-1083; DOI: https://doi.org/10.1124/pharmrev.120.000191

  3. Rezaei, Masoud

    1. Open Access
      Unlocking G-Quadruplexes as Antiviral Targets
      Ardavan Abiri, Marc Lavigne, Masoud Rezaei, Sanaz Nikzad, Peyman Zare, Jean-Louis Mergny and Hamid-Reza Rahimi
      Rhian Touyz, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 897-923; DOI: https://doi.org/10.1124/pharmrev.120.000230

  4. Rižner, Tea Lanišnik

    1. Aldo-Keto Reductases and Cancer Drug Resistance
      Open Access
      Aldo-Keto Reductases and Cancer Drug Resistance
      Trevor M. Penning, Sravan Jonnalagadda, Paul C. Trippier and Tea Lanišnik Rižner
      Michael Gottesman, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1150-1171; DOI: https://doi.org/10.1124/pharmrev.120.000122

  5. Rombaut, Ben

    1. The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors
      Dean Paes, Melissa Schepers, Ben Rombaut, Daniel van den Hove, Tim Vanmierlo and Jos Prickaerts
      Martin Michel, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1016-1049; DOI: https://doi.org/10.1124/pharmrev.120.000273

S

  1. Satin, Leslie S.

    1. New Aspects of Diabetes Research and Therapeutic Development
      Leslie S. Satin, Scott A. Soleimanpour and Emily M. Walker
      Lori Isom, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1001-1015; DOI: https://doi.org/10.1124/pharmrev.120.000160

  2. Schepers, Melissa

    1. The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors
      Dean Paes, Melissa Schepers, Ben Rombaut, Daniel van den Hove, Tim Vanmierlo and Jos Prickaerts
      Martin Michel, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1016-1049; DOI: https://doi.org/10.1124/pharmrev.120.000273

  3. Sernoskie, Samantha Christine

    1. The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions
      Open Access
      The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions
      Samantha Christine Sernoskie, Alison Jee and Jack Paul Uetrecht
      Eric Barker, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 861-896; DOI: https://doi.org/10.1124/pharmrev.120.000090

  4. Shaham, Yavin

    1. Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review
      Ida Fredriksson, Marco Venniro, David J. Reiner, Jonathan J. Chow, Jennifer M. Bossert and Yavin Shaham
      Michael Nader, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1050-1083; DOI: https://doi.org/10.1124/pharmrev.120.000191

  5. Soleimanpour, Scott A.

    1. New Aspects of Diabetes Research and Therapeutic Development
      Leslie S. Satin, Scott A. Soleimanpour and Emily M. Walker
      Lori Isom, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1001-1015; DOI: https://doi.org/10.1124/pharmrev.120.000160

  6. Stewart, Alastair G.

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

T

  1. Touyz, Rhian

    1. Open Access
      Unlocking G-Quadruplexes as Antiviral Targets
      Ardavan Abiri, Marc Lavigne, Masoud Rezaei, Sanaz Nikzad, Peyman Zare, Jean-Louis Mergny and Hamid-Reza Rahimi
      Rhian Touyz, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 897-923; DOI: https://doi.org/10.1124/pharmrev.120.000230

  2. Treadway, Michael T.

    1. Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
      Michael J. Lucido, Mandy Bekhbat, David R. Goldsmith, Michael T. Treadway, Ebrahim Haroon, Jennifer C. Felger and Andrew H. Miller
      Robert Dantzer, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1084-1117; DOI: https://doi.org/10.1124/pharmrev.120.000043

  3. Trippier, Paul C.

    1. Aldo-Keto Reductases and Cancer Drug Resistance
      Open Access
      Aldo-Keto Reductases and Cancer Drug Resistance
      Trevor M. Penning, Sravan Jonnalagadda, Paul C. Trippier and Tea Lanišnik Rižner
      Michael Gottesman, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1150-1171; DOI: https://doi.org/10.1124/pharmrev.120.000122

U

  1. Uetrecht, Jack Paul

    1. The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions
      Open Access
      The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions
      Samantha Christine Sernoskie, Alison Jee and Jack Paul Uetrecht
      Eric Barker, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 861-896; DOI: https://doi.org/10.1124/pharmrev.120.000090

V

  1. van den Hove, Daniel

    1. The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors
      Dean Paes, Melissa Schepers, Ben Rombaut, Daniel van den Hove, Tim Vanmierlo and Jos Prickaerts
      Martin Michel, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1016-1049; DOI: https://doi.org/10.1124/pharmrev.120.000273

  2. Vanmierlo, Tim

    1. The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors
      Dean Paes, Melissa Schepers, Ben Rombaut, Daniel van den Hove, Tim Vanmierlo and Jos Prickaerts
      Martin Michel, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1016-1049; DOI: https://doi.org/10.1124/pharmrev.120.000273

  3. Venniro, Marco

    1. Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review
      Ida Fredriksson, Marco Venniro, David J. Reiner, Jonathan J. Chow, Jennifer M. Bossert and Yavin Shaham
      Michael Nader, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1050-1083; DOI: https://doi.org/10.1124/pharmrev.120.000191

W

  1. Walker, Emily M.

    1. New Aspects of Diabetes Research and Therapeutic Development
      Leslie S. Satin, Scott A. Soleimanpour and Emily M. Walker
      Lori Isom, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 1001-1015; DOI: https://doi.org/10.1124/pharmrev.120.000160

  2. Weng, Jianping

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

X

  1. Xu, Suowen

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096

Z

  1. Zare, Peyman

    1. Open Access
      Unlocking G-Quadruplexes as Antiviral Targets
      Ardavan Abiri, Marc Lavigne, Masoud Rezaei, Sanaz Nikzad, Peyman Zare, Jean-Louis Mergny and Hamid-Reza Rahimi
      Rhian Touyz, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 897-923; DOI: https://doi.org/10.1124/pharmrev.120.000230

  2. Zheng, Xueying

    1. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
      Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart and Jianping Weng
      Qiang Ma, ASSOCIATE EDITOR
      Pharmacological Reviews July 2021, 73 (3) 924-967; DOI: https://doi.org/10.1124/pharmrev.120.000096
Back to top

In this issue

Advertisement